California Wildfires in the 2010s Exacerbated Psychotropic Medication Prescriptions
Drug Topics
MARCH 13, 2024
Researchers studied the effect of wildfires on mental health in California from 2011 to 2018.
2011 Related Topics 
STAT+: With big ambition — and a family name to match — Reed Jobs charts his own course in biotech
STAT
DECEMBER 12, 2023
He was a sophomore studying biology at Stanford University and, up until October 2011, had always planned to pursue a career in cancer research. In the months after his father died of complications from pancreatic cancer, Reed Jobs found it difficult to go back to life as it was before.
144 Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
US Congress passes bill to end Parkinson’s disease
pharmaphorum
MAY 30, 2024
The US Congress has passed the first-ever federal bill dedicated to ending Parkinson’s disease, modelled on similar legislation for Alzheimer’s enacted in 2011
119 
M&A or affiliation improved rural hospitals' margins, reduced risk of closure: report
Fierce Healthcare
DECEMBER 2, 2024
The analysis, conducted by healthcare consulting firm Dobson DaVanzo, found that among 110 rural hospitals that closed between 2011 and 2021, more than half were standalone hospitals without support from larger systems.
Hospitals 130
130 Hospitals 130
130 
More than 70 babies have been born from uterus transplants: ‘It’s a complete new world’
STAT
AUGUST 16, 2024
The first successful transplant was performed in 2011 — but even then, the recipient wasn’t immediately able to get pregnant and deliver a baby. The first modern attempt at transferring a uterus from one human to another occurred at the turn of the millennium.
141 
Opinion: The FDA’s risky action on compounding weight loss drugs
STAT
NOVEMBER 19, 2024
When Makena, a drug designed to prevent preterm births, hit the market in 2011 at $1,500 per dose, it drew rife backlash. The drug was based on an active ingredient that had been available for many years at a much lower cost.
Compounding 145
145 
STAT+: Documents detail how pharmacy giants Walgreens, CVS, and Walmart failed patients in the opioid epidemic
STAT
OCTOBER 14, 2022
In 2011, Walgreens executives were under pressure. Amid a growing addiction crisis, and with the country already awash in prescription painkillers, the federal government was demanding accountability from the pharmacy giant for filling thousands of opioid prescriptions written by doctors in suspiciously large quantities.
Documentation 121
121 Documentation 121
121 
BCGP Exam Study Tips – I Passed! (Again)
Med Ed 101
JUNE 16, 2024
I’ve maintained my BCGP certification (formerly CGP) since 2011. I’m happy to report this was the third time I’ve taken and passed the exam (and recertification exam). I can safely say that I feel […] The post BCGP Exam Study Tips – I Passed! Again) appeared first on Med Ed 101.
105 
Opinion: It’s time to rethink the Medicare annual wellness visit
STAT
DECEMBER 12, 2023
In 2011, the Centers for Medicare and Medicaid Services created the annual wellness visit (AWV), a new visit type with no cost to Medicare patients, better reimbursement to primary care practices, and higher assigned credit for clinicians’ work.
Insurance 126
126 Insurance 126
126 
Why AstraZeneca’s CEO is accusing British tabloids of ‘fake news’
STAT
OCTOBER 24, 2023
Damian here with news of a 2021-sized biotech round that has echoes of 2011, plus an ESMO recap and a curious stock move. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, everyone. Read the rest…
FDA 106
106 FDA 106
106 
STAT+: Medicare Advantage insurers will score $2 billion gift thanks to limited audits
STAT
FEBRUARY 1, 2023
” But based on a final regulation published Monday, Medicare is going against that public interest by giving a free pass to Medicare Advantage plans for any erroneous codes they submitted between 2011 and 2017. The amount of taxpayer money that insurers will get to keep because of that decision: $2 billion.
Insurance 111
111 Insurance 111
111 
FTC withdraws 'outdated' healthcare antitrust policy statements, following DOJ's lead
Fierce Healthcare
JULY 17, 2023
Friday, the Federal Trade Commission (FTC) announced its withdrawal of two policy statements outlining its former position on antitrust enforcement in healthcare markets, echoing a similar decision | The two policy statements, issued in 1996 and 2011, "no longer reflect market realities in this important sector of the economy," the regulator (..)
98 
‘We’re failing to make progress’: Studies show ongoing toll of premature Black deaths
STAT
MAY 16, 2023
The analysis showed improvement was made in narrowing long-standing health gaps between Black and white Americans between 1999 and 2011, but progress stalled through 2019. In the last two decades, Black Americans have suffered 1.63
111 
STAT+: Akili to lay off 46% of its staff, explore strategic options amid sluggish sales
STAT
APRIL 30, 2024
Founded in 2011, Akili Interactive made waves in 2020 when it received Food and Drug Administration clearance for EndeavorRx , its treatment for young people with ADHD. Earlier this year, Better Therapeutics, developer of an FDA-cleared app for the treatment of type 2 diabetes shut down operations.
Insurance 121
121 
PTC inks Royalty deal worth up to $1.5B on Genentech-partnered SMA drug Evrydsi
Fierce Pharma
OCTOBER 19, 2023
The company licensed the med to Genentech in 2011. Amid a cost-cutting drive and a looming commercial threat in Europe, PTC Ther | PTC will hold on to 19% of its royalty interest in the Genentech drug with the option to sell the rest down the line.
93 
Opinion: What the Makena vote means about accelerated approval, trust, and the FDA
STAT
OCTOBER 19, 2022
In 2011, the same year that Makena received accelerated approval from the FDA, I was a member of a similar FDA advisory committee hearing in which we considered withdrawing the breast cancer indication for the drug Avastin. We’ve been here before.
FDA 101
101 FDA 101
101 
STAT+: Regeneron’s Eylea sales dip, as competition looms
STAT
JANUARY 9, 2023
Wall Street had been watching sales figures closely, for fear that competition from biosimilars — a form of generic — and new medicines from rival drugmakers could cut into the sales that have fueled Regeneron’s growth since Eylea was approved in 2011. Continue to STAT+ to read the full story…
101 
STAT+: Sales of antibiotics for food-producing animals dropped by more than half in Europe over the past decade
STAT
NOVEMBER 27, 2023
Amid concerns over the use of medically important antibiotics given to food-producing livestock, sales of veterinary medicines across Europe dropped by 53% between 2011 and 2022, which regulators reported is the biggest drop ever recorded and a sign that campaigns to reduce usage are working.
113 
STAT+: Sales of antibiotics for food-producing animals dropped by nearly half in Europe over the past decade
STAT
NOVEMBER 18, 2022
Amid ongoing concerns over the use of medically important antibiotics given to food-producing livestock and farmed fish, sales of veterinary medicines across Europe dropped by nearly half between 2011 and 2021, which regulators reported is the biggest drop ever recorded and a sign that campaigns to reduce use are working.
98 
STAT+: DarioHealth acquires Twill, hoping it’s a shortcut to profitability
STAT
FEBRUARY 21, 2024
Founded in 2011, Dario started with a diabetes app targeted at consumers before expanding it to hypertension and weight management. The move is a bet that a consolidated offering can attract a critical mass of large customers in a market where profits have been elusive.
117 
Opinion: Rural hospitals are closing labor and delivery services. Babies’ lives are in jeopardy
STAT
APRIL 18, 2023
A February 2023 report from Chartis , a health care consulting firm, found that 217 labor and delivery units have closed across the nation since 2011. The trend of rural hospitals shuttering perinatal services is not new. When these facilities close, the care of both pregnant people and their newborns must occur elsewhere.
Hospitals 98
98 Hospitals 98
98 
Opinion: Former Sen. Max Baucus: Breakthrough Alzheimer’s drugs are out of reach for many in rural states like Montana
STAT
AUGUST 3, 2023
In 2011, President Obama signed the National Alzheimer’s Project Act into law, establishing a national goal of preventing and effectively treating the disease by 2025. Medicare’s policies are creating obstacles that make it more difficult for patients who are highly likely to benefit to obtain access to diagnosis and treatment.
98 
CRISPR pioneers Doudna and Charpentier claim Nobel chemistry prize
pharmaphorum
OCTOBER 7, 2020
She published her findings in 2011, and later that year started collaborating with Doudna, a biochemistry specialist. In 2011, Emmanuelle Charpentier and Jennifer Doudna had no idea that their first meeting, in a café in Puerto Rico, would be life-changing. — The Nobel Prize (@NobelPrize) October 7, 2020.
105 
STAT+: Pharmalittle: We’re reading about Novo’s Wegovy approval in China, a Merck KGaA cancer trial failure, and more
STAT
JUNE 25, 2024
The justices threw out a lower court ruling that revived a lawsuit brought by the military personnel and civilians who said they were harmed between 2005 and 2011 in the Iraq war. The justices asked the lower court to reconsider the case.
108 
Gerry Potter obituary
The Guardian - Pharmaceutical Industry
MARCH 3, 2023
It was patented in 1993, eventually approved in 2011 and is now one of the leading treatments of advanced prostate cancer, branded as Zytiga. In the early 1990s, he and his colleagues at the Institute of Cancer Research in London designed the hormone therapy drug abiraterone acetate.
75 
Evernorth: Use of ICI therapies to treat cancer is growing. Here's what payers need to know
Fierce Healthcare
AUGUST 14, 2023
The number of cancer patients using immune checkpoint inhibitor drugs has steadily risen since they hit the market in 2011, and a new report from Evernorth offers payers key strategies to manage th | The number of cancer patients using immune checkpoint inhibitor drugs has steadily risen since they hit the market in 2011, and a new report from Evernorth (..)
Immunization 52
52 Immunization 52
52 
Pharma bad boy Martin Shkreli is on the streets again
pharmaphorum
MAY 19, 2022
He was found guilty in 2017 of securities fraud schemes involving two hedge funds that he ran, sending fake account statements in order to conceal huge losses, and also convicted of manipulating the price and trading volume of stock in Retrophin, another pharma company he founded in 2011. In January, Shkreli was ordered to repay $64.6
21 
7 Best Metformin Alternatives For Type 2 Diabetes
Druggist
MAY 6, 2021
Modified-release metformin provide better gastrointestinal tolerability (Jabbour & Ziring, 2011). Ahrén B, Schweizer A, Dejager S, Villhauer EB, Dunning BE, Foley JE (2011). 2011 Sep;13(9):775-83. Jabbour S, Ziring B (2011). 2011 Jan;123(1):15-23. Gliptins also reduce the production of glucose by the liver.
Pacira BioSciences Announces FDA Approval of Expanded Indications for Exparel
Pharmaceutical Commerce
NOVEMBER 13, 2023
Exparel was initially approved in 2011 for single-dose infiltration into a surgical site.
FDA 52
52 FDA 52
52 
Antibiotics For Pediatric Respiratory Tract Infections In The Era Of Amoxicillin Shortages
IDStewardship
DECEMBER 22, 2022
Pediatric community acquired pneumonia is commonly viral and since the now archived 2011 IDSA CAP guidelines observation without antibiotics is given as an option for the preschool age group. Given the difficulty of giving oral medications to toddlers I can see the appeal of this injectable option. Community Acquired Pneumonia (CAP).
246 
The EU HTA regulation: a new frontier for access to innovative technologies
European Pharmaceutical Review
AUGUST 23, 2022
To achieve this objective, the regulation amends Directive 2011/24/EU on the application of patients’ rights in cross?border Directive 2011/24/EU had the merit of drawing attention to the need for an appropriate and centralised assessment of health technologies but failed to ensure effective harmonisation on the issue. Lorgelly PK.,
98 
FDA extends review of GSK’s myelofibrosis drug
Pharmaceutical Technology
JUNE 19, 2023
Novartis and Incyte Corp’s Jakafi was the first FDA-approved drug for the treatment of myelofibrosis in November 2011. First-in-line treatment for myelofibrosis currently involves treatment with Jakafi (ruxolitinib) in combination with other drugs such as danazol.
FDA 98
98 FDA 98
98 
5-alpha reductase inhibitor use does not increase prostate cancer mortality
Hospital Pharmacy Europe
APRIL 27, 2023
However, the FDA warned in 2011 that 5-ARIs may increase the risk of a more serious form of prostate cancer. A 2003 study suggested that 5-alpha reductase inhibitors (5-ARIs) such as finasteride, prevent or delay the appearance of prostate cancer. In addition, use of dutasteride, also gave rise to a lower risk of incident prostate cancer.
Hospitals 98
98 
Minneceutics Newsletter
Blog: Ask a Student Pharmacist
OCTOBER 4, 2023
Minneceutics Newsletter eomizowh Wed, 10/04/2023 - 12:47 Current Newsletter Expand all + Archive 1993 1994 1995 1999 2000 2001 2002 2003 2004 2006 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
52 
STAT+: Pharmalittle: We’re reading about Novo targeting compounded obesity drugs, an Amgen ‘at risk’ launch, and more
STAT
OCTOBER 23, 2024
regulators in 2011. Court of Appeals for the Federal Circuit rejected Regeneron’s request to block the launch during its appeal of a related decision for Amgen in a patent case in West Virginia. Eylea can treat eye diseases like macular degeneration, macular edema, and retinopathy, and was first approved by U.S. billion in U.S.
Compounding 103
103 
FDA withdraws approval of preterm birth drug Makena
Pharmaceutical Technology
APRIL 7, 2023
Makena was approved by the FDA under the accelerated approval pathway in 2011 to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of spontaneous preterm birth. The decision was made after studies did not prove the effectiveness of the drug in preventing preterm birth.
FDA 97
97 FDA 97
97 
Martin Shkreli’s $7.4m forfeit is paid, thanks to that Wu-Tang Clan album
pharmaphorum
JULY 28, 2021
He was also convicted of manipulating the price and trading volume of stock in Retrophin, another pharma company he founded in 2011. He was subsequently found guilty of securities fraud schemes involving two hedge funds that he ran, sending fake account statements in order to conceal huge losses. By Wutangcashew – I photographed it.
105 
FDA withdraws approval of preterm birth drug Makena
Pharmaceutical Technology
APRIL 7, 2023
Makena was approved by the FDA under the accelerated approval pathway in 2011 to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of spontaneous preterm birth. The decision was made after studies did not prove the effectiveness of the drug in preventing preterm birth.
FDA 95
95 FDA 95
95 
Togo becomes first country to eliminate four neglected tropical diseases
Pharmafile
AUGUST 24, 2022
The West African nation has successfully eliminated dracunculiasis (Guinea worm disease), elephantiasis (lymphatic filariasis), human African trypanosomiasis (sleeping sickness) and trachoma, in an effort spanning between 2011 and 2022. read more.
52 
From Healing to Harm: The Unintended Consequences of Polypharmacy in Seniors
PharmD Live
MAY 30, 2024
The psychological strain of managing chronic illnesses alongside polypharmacy can diminish a patient’s quality of life, making everyday tasks more challenging and increasing the risk of mental health disorders (Jyrkka et al., Stay tuned for Part 3, where we will discuss identifying and addressing polypharmacy. References: Budnitz, D.
Hospitals 119
119 
New antibody drug formulation wins novel MHRA approval
European Pharmaceutical Review
MARCH 1, 2024
MHRA confirmed that this new marketing authorisation was granted to Amgen Limited, as a line extension of the original marketing authorisation for XGEVA 120mg solution for injection, which was granted on 13 July 2011. The post New antibody drug formulation wins novel MHRA approval appeared first on European Pharmaceutical Review.
97 
Takeda, Daiichi-backed wearable study planned in Japan
pharmaphorum
MAY 23, 2022
The results generated in the study will be combined with data from Tohoku’s Medical Megabank Project (TMM), a wide-ranging national project that is tracking the health of the Japanese population, originally set up in response to the 2011 earthquake and tsunami.
90 
Rare disease insights from the patient community
pharmaphorum
FEBRUARY 25, 2021
Consisting of two separate companies, Bedrock Healthcare Communications and Origins Insights , Bedrock Group has grown from a small UK based start-up consultancy in 2011, to an award-winning leading player in health experience research, international strategic medical communications and creative medical education in 2019.
BMS’ Orencia gets FDA nod for GvHD thanks to real-world data
pharmaphorum
DECEMBER 15, 2021
Orencia has been on the market for rheumatoid arthritis since 2995, with an additional FDA approval for a subcutaneous formulation in 2011 and new indications in psoriatic arthritis and juvenile idiopathic arthritis helping the drug become BMS’ fourth-largest product with sales of $2.44 billion in the first nine months of the year.
FDA 105
105 
Let's personalize your content